Barclays
HIT

Barclays’s Health In Tech Inc HIT Stock Holding History

Barclays’s Portfolio HIT Stock Details HIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$726 Buy
+719
New +$893 ﹤0.01% 4960

Other funds holding HIT

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Barclays's HIT Position: Q2 2026 in Review

Barclays opened a new position in Health In Tech Inc (HIT) in Q2 2026: 719 shares worth $726. The stake represents ﹤0.01% of the portfolio and ranks #4960 among its holdings.

21 funds tracked by Wall St. Rank hold HIT as of Q2 2026.

  • Barclays held 719 shares of Health In Tech Inc worth $726 as of Q2 2026.
  • Health In Tech Inc was a new Barclays position in Q2 2026.
  • Health In Tech Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4960 holding.
  • 21 funds tracked by Wall St. Rank held Health In Tech Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.